Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000902664-25-004954·HIGHBRIDGE CAPITAL MANAGEMENT LLC
Schedule 13G ownership disclosure
Karyopharm Therapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 48576U205
Event date: 2025-09-30
- Filing-level shares
- 649,984.00
- Percent of class
- 4.9%
- HIGHBRIDGE CAPITAL MANAGEMENT, LLC
Shares: 649,984.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-004954
- Form type
- SCHEDULE 13G/A
- Filer
- HIGHBRIDGE CAPITAL MANAGEMENT LLC
- CIK
- CIK 919185
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership